ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.567
+0.042 (8.04%)
Nov 20, 2024, 4:00 PM EST - Market closed
ABVC BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7 | 9 | 20 | 96 | 105 | 84 | |
| Market Cap Growth | 93.67% | -55.74% | -78.95% | -8.30% | 24.82% | -80.39% | |
| Enterprise Value | 9 | 12 | 22 | 95 | 109 | 87 | |
| Last Close Price | 0.57 | 1.16 | 6.25 | 33.90 | 51.00 | 43.70 | |
| PS Ratio | 11.18 | 58.72 | 20.85 | 269.96 | 216.85 | 119.59 | |
| PB Ratio | 0.84 | 1.10 | 6.25 | 10.83 | 39.35 | -672.31 | |
| P/TBV Ratio | 0.98 | 1.07 | 6.53 | 10.86 | 30.46 | - | |
| EV/Sales Ratio | 16.75 | 80.24 | 22.60 | 266.23 | 225.31 | 124.60 | |
| Debt / Equity Ratio | 0.29 | 0.30 | 1.06 | 0.38 | 2.54 | -39.56 | |
| Asset Turnover | 0.03 | 0.01 | 0.08 | 0.03 | 0.05 | 0.11 | |
| Inventory Turnover | - | - | - | 0.39 | - | 30.56 | |
| Quick Ratio | 0.23 | 0.03 | 0.18 | 1.72 | 0.97 | 0.08 | |
| Current Ratio | 0.34 | 0.28 | 0.54 | 2.07 | 1.27 | 0.13 | |
| Return on Equity (ROE) | -102.32% | -191.96% | -269.48% | -208.73% | -835.04% | - | |
| Return on Assets (ROA) | -25.30% | -42.67% | -81.16% | -57.82% | -57.36% | -33.60% | |
| Return on Capital (ROIC) | -33.79% | -59.60% | -100.17% | -67.64% | -74.68% | -220.20% | |
| Earnings Yield | -121.21% | -117.48% | -81.21% | -13.37% | -9.35% | -4.34% | |
| FCF Yield | -26.39% | -47.56% | -37.18% | -7.93% | -4.36% | -3.74% | |
| Buyback Yield / Dilution | -187.47% | -36.92% | -26.39% | -27.07% | -12.67% | -47.26% | |
| Total Shareholder Return | -187.47% | -36.92% | -26.39% | -27.07% | -12.67% | -47.26% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.